Z-0506-2016 Class III Terminated

Recalled by Ameditech Inc — San Diego, CA

FDA device recall Z-0506-2016 was initiated by Ameditech Inc on Nov 16, 2015 and is designated Class III. Reason for recall: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the… The recall status is terminated (terminated Nov 9, 2016). Affected quantity: 8,290 units.

Recall details

Product Type
Devices
Report Date
Dec 30, 2015
Initiation Date
Nov 16, 2015
Termination Date
Nov 9, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8,290 units

Product description

iCup DX 8 Panel w/Adulterant, Item No. I-DXA-187-016

Reason for recall

Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.

Distribution pattern

Nationwide Distribution.

Code information

141971 142195 142397 142674 142997 144209 144463 150018 150883 151525 151526 152180 152741 153045 153150 153151 153211 153376 153650

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0506-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0506-2016. Report a data issue: hello@regdatalab.com.